Intelligent Bio Solutions Reports 98.2% Accuracy in Drug Testing
NEW YORK, September 2, 2026 Intelligent Bio Solutions Inc. has reported strong performance results for its Intelligent Fingerprinting Drug...
Medical Devices, Diagnostics, Radiation-Emitting Products
Telix Completes BiPASS Enrollment and Aligns With FDA
MELBOURNE, Australia and INDIANAPOLIS, September 2, 2026 Telix Pharmaceuticals Limited has completed enrollment of 350 patients in its Phase...
Butterfly Network Partners With Merge Labs on Ultrasound BCI
BURLINGTON, Mass. & NEW YORK, September 1, 2026 Butterfly Network, Inc. and Merge Labs have entered a multi-year licensing...
Guardant Health Expands Shield CRC Screening Coverage
PALO ALTO, Calif., Sept. 1, 2026 Guardant Health announced that its Shield blood test for colorectal cancer (CRC) screening...
Natera Validates Signatera for Lymphoma MRD Assessment
AUSTIN, Texas, September 1, 2026 Natera announced publication of new clinical data in Blood Neoplasia supporting the prognostic and...
GE HealthCare Photonova Spectra Gains CE Mark for CT
CHICAGO, August 31, 2026 GE HealthCare announced that its Photonova™ Spectra photon-counting computed tomography (PCCT) system has received CE...
Beyond Air Wins FDA Breakthrough Device Status for LungFit GO
Garden City, N.Y. – August 31, 2026 Beyond Air announced that the U.S. Food and Drug Administration has granted...
Bayer Reports Phase 3 PET Data in Cardiac Amyloidosis
Berlin, Germany, August 30, 2026 Bayer announced detailed results from the Phase 3 REVEAL study evaluating investigational PET radiotracer...
Vesalio’s enVast Meets NATURE Trial Endpoint in STEMI
Dallas, Texas, August 29, 2026 Vesalio announced positive results from the NATURE randomized controlled trial, evaluating the company’s enVast™...
Roche Wins FDA Clearance for Elecsys pTau217 Test
INDIANAPOLIS, U.S., Aug 28, 2026 Roche has received U.S. FDA clearance for Elecsys® Phospho-Tau (217P) Plasma (pTau217), a blood-based...